Asarina Pharma

1 following

ShowingAll content types

Regulatory press release9/16/2024, 6:00 PM

Asarina Pharma AB (publ) shares to be delisted and the last day of trading is 1 October 2024

Regulatory press release9/13/2024, 9:00 AM

Asarina Pharma applies for the delisting of the company's shares

Regulatory press release8/21/2024, 9:30 AM

Bulletin from the extraordinary general meeting and first control meeting in Asarina Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release7/22/2024, 6:00 AM

NOTICE OF EXTRAORDINARY GENERAL MEETING AND FIRST CONTROL MEETING IN ASARINA PHARMA AB (PUBL)

Regulatory press release7/18/2024, 3:45 PM

ASARINA PHARMA ANNOUNCES OUTCOME OF PARTNERING PROCESS, CONTROL BALANCE SHEET AND PROPOSAL TO LIQUIDATE

Regulatory press release6/27/2024, 9:33 AM

Bulletin from the Annual General Meeting of Asarina Pharma AB (publ)

Regulatory press release6/4/2024, 8:54 PM

ASARINA PHARMA AB (PUBL) RELEASES ANNUAL REPORT 2023

Regulatory press release5/28/2024, 8:00 PM

Asarina Pharma AB announces new date for the release of Annual Report for 2023

Regulatory press release5/21/2024, 9:50 AM

Asarina Pharma AB announces new date for the release of Annual Report for 2023

Regulatory press release2/27/2024, 7:30 AM

ASARINA PHARMA AB (PUBL) RELEASES YEAR-END REPORT 2023

Regulatory press release11/30/2023, 9:30 AM

Asarina Pharma AB changes Certified Adviser to Carnegie Investment Bank AB

Regulatory press release11/16/2023, 7:33 AM

Asarina Pharma updates on partnering and financials

Regulatory press release8/23/2023, 6:30 AM

Asarina Pharma AB (publ) releases First Half-Year Report (H1/2023)

Regulatory press release5/23/2023, 7:02 AM

Positive Tourette Syndrome results to be presented at ESSTS, 15th European Conference on Tourette Syndrome and Tic Disorders

Regulatory press release5/22/2023, 9:15 AM

Bulletin from the Annual General Meeting of Asarina Pharma AB (publ)

Regulatory press release5/5/2023, 11:33 AM

Asarina Pharma's positive Phase IIa Tourette Syndrome results to be presented at TicCon, the Virtual National Conference of the Tourette Association of America

Regulatory press release4/28/2023, 6:30 PM

Asarina Pharma AB (publ) releases Annual Report 2022

Regulatory press release4/18/2023, 8:39 AM

Asarina Pharma: NOTICE OF ANNUAL GENERAL MEETING IN ASARINA PHARMA AB (PUBL)

Regulatory press release4/1/2023, 12:20 PM

Asarina Pharma publishes positive results from its Phase IIa study of Sepranolone in Tourette Syndrome

Regulatory press release2/27/2023, 7:30 AM

Asarina Pharma AB (publ) releases Year-End Report 2022

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.